ASKA Pharmaceutical Holdings Co.,Ltd.
4886
Rank in Stocks
#13552
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates... ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Share Price
$13.43
Last synced: 2026-11-10
Market Cap
$381.94M
Change (1 day)
1.78%
Change (1 year)
1.74%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade ASKA Pharmaceutical Holdings Co.,Ltd. (4886)
Category
Healthcare
Operating Margin for ASKA Pharmaceutical Holdings Co.,Ltd. (4886)
Operating Margin as of November 2026 TTM: 7.15%
According to ASKA Pharmaceutical Holdings Co.,Ltd.'s latest financial reports, its current operating margin (TTM) is 7.15%. At the end of 2025 the company had an operating margin of 8.31%.
Operating Margin history for ASKA Pharmaceutical Holdings Co.,Ltd. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.15% | -13.96% |
| 2025 | 8.31% | -19.63% |
| 2024 | 10.34% | 22.37% |
| 2023 | 8.45% | -0.24% |
| 2022 | 8.47% | 29.51% |
| 2021 | 6.54% | 127.87% |
| 2020 | 2.87% | -24.87% |
| 2019 | 3.82% | -33.80% |
| 2018 | 5.77% | 55.95% |
| 2017 | 3.70% | 37.04% |
| 2016 | 2.70% | -17.93% |
| 2015 | 3.29% | 84.83% |
| 2014 | 1.78% | -30.47% |
| 2013 | 2.56% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -97.29% |
DE
|
|
| 19.68% | -97.25% |
DE
|
|
| 13.26% | -98.15% |
JP
|
|
| 17.08% | -97.61% |
CH
|
|
| 14.92% | -97.91% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin
What is ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin?
ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin is 7.15%, as of Nov 2026.
What was ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin in 2025?
In 2025, ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin was 8.31%, compared with 10.34% in 2024.
How has ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin changed since 2020?
From 2020 to 2025, ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin was highest in 2024 (10.34%) and lowest in 2020 (2.87%).
How does ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin compare with similar companies?
ASKA Pharmaceutical Holdings Co.,Ltd.'s operating margin (7.15%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.